{"id":"W3200845029","doi":"10.1182/bloodadvances.2021004765","title":"Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Center for Advancing Translational Sciences; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Winship Cancer Institute; Seagen; Incyte; Astellas Pharma; Adaptive Biotechnologies; TG Therapeutics; H. Lundbeck A/S; BeiGene; Purdue Pharma; Regeneron Pharmaceuticals; National Institutes of Health; Ohio State University; Omeros Corporation; Verastem Oncology; Spectrum Pharmaceuticals; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; Purdue University; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Emory University","keywords":"Medicine; Intensive care; Oncology; Internal medicine; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006955399,0.0002390652,0.0004387573,0.0005911711,0.0002967001,0.0008415186,0.0003298969,0.0004765772,0.001227485],"category_scores_gemma":[0.002309997,0.0001555896,0.0003822744,0.0005019071,0.0002799891,0.0005442532,0.0005210611,0.0005090873,0.0002240382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003135608,"about_ca_system_score_gemma":0.00019716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009663256,"about_ca_topic_score_gemma":0.001562805,"domain_scores_codex":[0.9995851,0.0001120241,0.00004118375,0.00009068177,0.00006552644,0.000105455],"domain_scores_gemma":[0.998116,0.0004748994,0.000842298,0.0001219917,0.0001146841,0.0003301539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006883594,0.00002625427,0.9942736,0.000005971941,0.00002911143,0.0001213227,0.00005119365,0.00009196631,0.0008437722,0.0000153922,0.0000646352,0.003788392],"study_design_scores_gemma":[0.00001782155,0.0002351679,0.9981855,0.000006675751,0.00003295441,0.000635169,0.0000969584,0.0004335543,0.0001452905,0.00005467184,0.0001507009,0.000005553817],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995191,0.0001786579,0.00003981966,0.00002331353,0.000002481311,0.000002997406,0.00005398699,0.000002984456,0.0001767229],"genre_scores_gemma":[0.9996355,0.00004918925,0.00003982848,0.00002439179,0.00001262862,0.000002375138,0.0001767631,0.000001415535,0.00005785522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001227485,"threshold_uncertainty_score":0.004106402,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01518086700201701,"score_gpt":0.2590935902796956,"score_spread":0.2439127232776786,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}